Clinical Trial Update: New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy [Phase 3]

View source ↗

Summary

A Phase 3 trial compares adjuvant chemotherapy alone to chemo-immunotherapy in non-small cell lung cancer. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Chemo-immunotherapy
• Chemotherapy (chemotherapy)

Snippet

Sponsor: Fundación GECP | Conditions: Non-Small Cell Lung Cancer, Adjuvant Chemotherapy | Phase 3 | Status: ACTIVE_NOT_RECRUITING